Mayo, Mercy collaborate on data use to speed disease diagnosis, treatment

Rochester, Minn.-based Mayo Clinic and Chesterfield, Mo.-based Mercy signed a 10 year agreement July 26 to use deidentified patient outcomes to pinpoint diseases earlier and identify best treatment options. 

Advertisement

Using cloud-based technology, artificial intelligence and machine learning, the two health systems will aggregate clinical deidentified data, according to a July 26 news release from Mercy. The information will help scientists analyze patterns of effective disease treatment and disease prevention in new ways based upon longitudinal data review over an extended period.

“With Mayo and Mercy combining efforts, we can speed prediction and diagnosis and provide better patient care, experience and outcomes, while ultimately saving more lives,” said Steve Mackin, president and CEO of Mercy. “We also hope to innovate together in other patient-focused areas, including precision medicine, transplant care, complex cancer, cardiovascular, neuroscience and much more. Together, we have the opportunity to do something for the greater good, be proactive and change healthcare for patients everywhere.”

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The hidden cost of lost clinical time and how leading health systems are responding

Friday, August 7
12:00 PM - 1:00 PM CDT

Presenters: Kassaundra McKnight-Young, Zebra TechnologiesGregory Carras, Zebra TechnologiesJennifer Gene, Levata

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.